Condensed Consolidated Statement of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid- In Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		12,823,665
Beginning balance at Dec. 31, 2023	$ 186,024	$ 0	$ 373,178	$ (187,154)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	1,045		1,045
Common stock issued upon exercise of stock options (in shares)		37,330
Common stock issued upon exercise of stock options	629		629
Net loss	(16,921)			(16,921)
Ending balance (in shares) at Mar. 31, 2024		12,860,995
Ending balance at Mar. 31, 2024	$ 170,777	$ 0	374,852	(204,075)
Beginning balance (in shares) at Dec. 31, 2024	14,854,725	14,854,725
Beginning balance at Dec. 31, 2024	$ 310,375	$ 0	572,673	(262,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 4,048		4,048
Common stock issued upon exercise of stock options (in shares)	1,683	1,683
Common stock issued upon exercise of stock options	$ 19		19
Common stock issued upon vesting of restricted stock units (in shares)		73,158
Net loss	$ (22,647)			(22,647)
Ending balance (in shares) at Mar. 31, 2025	14,929,566	14,929,566
Ending balance at Mar. 31, 2025	$ 291,795	$ 0	$ 576,740	$ (284,945)